Cutamesine is a selective sigma-1 receptor agonist currently investigated for its potential in treating neurodegenerative and psychiatric disorders, including depression, cognitive impairment, and brain… Read more
Cutamesine is a selective sigma-1 receptor agonist currently investigated for its potential in treating neurodegenerative and psychiatric disorders, including depression, cognitive impairment, and brain injury following stroke. This category provides a comprehensive selection of reference standards essential for analytical testing and quality control workflows involving this compound. Included in this collection are pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope-labelled compounds, which serve as critical tools for accurate impurity profiling, method development, and method validation. Pharmaceutical laboratories rely on these highly characterized materials to ensure precision and regulatory compliance during the identification and quantification of impurities in active pharmaceutical ingredients and finished products. By utilizing these standardized references, researchers can achieve consistent results in stability studies and bioanalytical assays throughout the drug development lifecycle.